ConductScience.org, home

Trial · NCT00316784

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

NCT00316784, Phase 3, Completed, IDEA AG

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA. Trials, record NCT00316784. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00316784

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA
NCT number
NCT00316784
Status
Completed
Phases
Phase 3
Enrollment
704 participants
Lead sponsor
IDEA AG
Conditions
Osteoarthritis; Knee
Interventions
IDEA-033 (and rescue medication)
First posted
2006-04-21
Last updated
2009-03-20

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarychange from baseline at week 12 (or end of study measurements) on the Visual Analogue Scale version of the entire WOMAC Pain subscale (primary)
Primarypatient global assessment of response to therapy measured on a 5-point Likert Scale at week 12 or end of study measurements (co-primary)
Primarychange from baseline at week 12 (or end of study measurements) on the Visual Analogue Scale version of the entire WOMAC function subscale (co-primary)
SecondaryChange from baseline at week 12 (or end of study measurements) for Physician's Global Assessment of OA and for observed function (TUG)
SecondaryMean number of rescue medication taken per day while in the study
SecondaryNumber of withdrawals and time to discontinuation of the study due to lack of efficacy
SecondaryTime to onset (in days) of pain relief and time to onset of new flares during treatment
SecondaryChange from baseline on the vitality subscale of the SF-36 health survey and the EURO QoL

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00316784

GET https://conductscience.org/api/trials/v1/NCT00316784/registered